TAYLOR HUINKER: Open Payments
NPI 1851881213 · MASON CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 45 payments from 15 companies in 2025. Trend: 2023 $486 · 2024 $811 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 11 | $164 |
| ABBVIE INC. | 7 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $118 |
| Phathom Pharmaceuticals, Inc. | 4 | $109 |
| Ipsen Biopharmaceuticals, Inc | 4 | $68 |
| Janssen Biotech, Inc. | 2 | $44 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Fresenius Kabi USA, LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
Products named: VEGZELMA, ENTYVIO, VOQUEZNA, RINVOQ, IQIRVO, DUPIXENT, TREMFYA, JOURNAVX.
Industry payments across IA — which companies pay providers there.
